Xtx Topco LTD Biotechnology

Xtx Topco LTD

$1.81 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
PRQR Pro Qr Therapeutics N.V.	$158M	$21,000 0.0% of portfolio	16,079	Q1 2025 Reduced 73.9%
IMMX Immix Biopharma, Inc.	$37M	$21,000 0.0% of portfolio	12,833	Q1 2025 New
IPSC Century Therapeutics, Inc.	$32.4M	$20,000 0.0% of portfolio	43,514	Q1 2025 Reduced 49.4%
GBIO Generation Bio Co.	$19.5M	$20,000 0.0% of portfolio	52,440	Q1 2025 New
RNXT Renovo Rx, Inc.	$11.8M	$20,000 0.0% of portfolio	20,344	Q1 2025 Added 60.95%
IMMP Immutep LTD	$146M	$19,000 0.0% of portfolio	11,071	Q1 2025 New
LCTX Lineage Cell Therapeutics, Inc.	$166M	$19,000 0.0% of portfolio	43,178	Q1 2025 New
PRLD Prelude Therapeutics Inc	$29.1M	$19,000 0.0% of portfolio	24,700	Q1 2025 Reduced 35.57%
RGLS Regulus Therapeutics Inc.	$119M	$19,000 0.0% of portfolio	11,418	Q1 2025 New
ENTX Entera Bio Ltd.	$51.3M	$18,000 0.0% of portfolio	10,859	Q1 2025 New
GERN Geron Corp	$518M	$18,000 0.0% of portfolio	11,499	Q1 2025 Reduced 94.79%
DYAI Dyadic International Inc	$27.3M	$16,000 0.0% of portfolio	12,402	Q1 2025 New
STRO Sutro Biopharma, Inc.	$39.1M	$16,000 0.0% of portfolio	25,166	Q1 2025 Added 15.39%
GALT Galectin Therapeutics Inc	$124M	$15,000 0.0% of portfolio	13,106	Q1 2025 Reduced 25.8%
PASG Passage Bio, Inc.	$22.9M	$15,000 0.0% of portfolio	45,402	Q1 2025 New
CMMB Chemomab Therapeutics Ltd.	$13.3M	$14,000 0.0% of portfolio	13,274	Q1 2025 Reduced 46.75%
RANI Rani Therapeutics Holdings, Inc.	$15.4M	$13,000 0.0% of portfolio	10,996	Q1 2025 Reduced 14.69%
XFOR X4 Pharmaceuticals, Inc	$115M	$13,000 0.0% of portfolio	57,803	Q1 2025 New
ATHA Athira Pharma, Inc.	$14.4M	$12,000 0.0% of portfolio	46,148	Q1 2025 Added 160.9%
SLGL Sol Gel Technologies Ltd.	$167M	$11,000 0.0% of portfolio	21,830	Q1 2025 New
INAB In8 Bio, Inc.	$53.2M	$11,000 0.0% of portfolio	69,708	Q1 2025 Added 64.41%
SPRB Spruce Biosciences, Inc.	$1.65M	$11,000 0.0% of portfolio	41,217	Q1 2025 Added 15.94%
AIM Aim Immuno Tech Inc.	$437M	$10,000 0.0% of portfolio	83,509	Q1 2025 Added 69.69%
CNTX Context Therapeutics Inc.	$10.2M	$9,000 0.0% of portfolio	15,673	Q1 2025 New
NXTC Next Cure, Inc.	$12.8M	$8,000 0.0% of portfolio	18,028	Q1 2025 Added 32.78%
IPA Immuno Precise Antibodies Ltd.	$41.7M	$7,000 0.0% of portfolio	18,485	Q1 2025 Reduced 21.0%
BOLT Bolt Biotherapeutics, Inc.	$231M	$6,000 0.0% of portfolio	15,392	Q1 2025 Reduced 65.71%
LXRX Lexicon Pharmaceuticals, Inc.	$166M	$5,000 0.0% of portfolio	12,471	Q1 2025 New
VIRX Viracta Therapeutics, Inc.	$376K	$1,000 0.0% of portfolio	93,391	Q1 2025 Added 530.64%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	49,647	Q1 2025 Added 54.1%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.